ELECO PUBLIC LIMITED COMPANY

Board/Management Information • Nov 7, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5071S

UDG Healthcare Public Limited Co.

07 November 2019

7 November 2019

UDG Healthcare plc

Corporate Broker Appointments

UDG Healthcare, a leading international healthcare services provider, announces it has appointed Liberum and Peel Hunt as joint corporate brokers along with Davy, whom UDG Healthcare retain as joint corporate broker.

ENDS

For further information, please contact:

Investors and Analysts: Keith Byrne SVP, IR, Strategy & Corporate Communications UDG Healthcare plc Tel: + 353-1-468-9000
Peel Hunt James Steel Tel: +44 20 7418 8900
Liberum John Fishley Tel: +44 (0)20 3100 2000
Davy Ronan Veale Tel: +353-1-679-7788
Powerscourt: Lisa Kavanagh / Jack Hickey Tel: + 44-207-250-1446

About UDG Healthcare plc

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 9,000 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield - Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three broad areas of activity: advisory, communications and commercial & clinical services. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp - Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state-of-the-art facilities in the US and Europe. 

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPEAAFKEFFNFFF